The Disruptors: The Biologic Revolution in Radiotherapies

Moderator

John Bishai, PhD

Global Healthcare Investment Banking, BofA Securities

Umar Mahmood, MD, PhD

Chief, Nuclear Medicine & Molecular Imaging, Massachusetts General Hospital;

Professor of Radiology, Harvard Medical School

Panelists

Amos Hedt

Chief Business Strategy Officer, Perspective Therapeutics

Lana Janes, PhD

Co-Founder & Chief Operating Officer, Abdera Therapeutics

Philip Kantoff, MD

Co-Founder & CEO, Convergent Therapeutics

Matthew Roden, PhD

President & CEO, Aktis Oncology

Matt Vincent, PhD

Chief Business Officer, AdvanCell Isotopes